These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8280122)

  • 1. Pioglitazone ameliorates high glucose induced desensitization of insulin receptor kinase in Rat 1 fibroblasts in culture.
    Maegawa H; Tachikawa-Ide R; Ugi S; Iwanishi M; Egawa K; Kikkawa R; Shigeta Y; Kashiwagi A
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1078-82. PubMed ID: 8280122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities.
    Maegawa H; Ide R; Hasegawa M; Ugi S; Egawa K; Iwanishi M; Kikkawa R; Shigeta Y; Kashiwagi A
    J Biol Chem; 1995 Mar; 270(13):7724-30. PubMed ID: 7535776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone increases insulin sensitivity by activating insulin receptor kinase.
    Kobayashi M; Iwanishi M; Egawa K; Shigeta Y
    Diabetes; 1992 Apr; 41(4):476-83. PubMed ID: 1318856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts.
    Kellerer M; Kroder G; Tippmer S; Berti L; Kiehn R; Mosthaf L; Häring H
    Diabetes; 1994 Mar; 43(3):447-53. PubMed ID: 7508875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pioglitazone on insulin receptors of skeletal muscles from high-fat-fed rats.
    Iwanishi M; Kobayashi M
    Metabolism; 1993 Aug; 42(8):1017-21. PubMed ID: 8345805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of insulin resistance and reversal by thiazolidinediones in C2C12 skeletal muscle cells.
    Kumar N; Dey CS
    Biochem Pharmacol; 2003 Jan; 65(2):249-57. PubMed ID: 12504800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats.
    Hayakawa T; Shiraki T; Morimoto T; Shii K; Ikeda H
    Biochem Biophys Res Commun; 1996 Jun; 223(2):439-44. PubMed ID: 8670300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.
    Iwata M; Haruta T; Usui I; Takata Y; Takano A; Uno T; Kawahara J; Ueno E; Sasaoka T; Ishibashi O; Kobayashi M
    Diabetes; 2001 May; 50(5):1083-92. PubMed ID: 11334412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes.
    Zhang B; Szalkowski D; Diaz E; Hayes N; Smith R; Berger J
    J Biol Chem; 1994 Oct; 269(41):25735-41. PubMed ID: 7929278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High glucose-induced abnormal epidermal growth factor signaling.
    Obata T; Maegawa H; Kashiwagi A; Pillay TS; Kikkawa R
    J Biochem; 1998 May; 123(5):813-20. PubMed ID: 9562610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glyburide but not ciglitazone enhances insulin action in the liver independent of insulin receptor kinase activation.
    Caro JF; Ittoop O; Sinha MK
    Metabolism; 1989 Jul; 38(7):606-11. PubMed ID: 2544783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
    Ishizuka T; Itaya S; Wada H; Ishizawa M; Kimura M; Kajita K; Kanoh Y; Miura A; Muto N; Yasuda K
    Diabetes; 1998 Sep; 47(9):1494-500. PubMed ID: 9726240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pioglitazone on vascular reactivity in vivo and in vitro.
    Kotchen TA; Zhang HY; Reddy S; Hoffmann RG
    Am J Physiol; 1996 Mar; 270(3 Pt 2):R660-6. PubMed ID: 8780234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin secretory defect in Zucker fa/fa rats is improved by ameliorating insulin resistance.
    de Souza CJ; Yu JH; Robinson DD; Ulrich RG; Meglasson MD
    Diabetes; 1995 Aug; 44(8):984-91. PubMed ID: 7622005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone-induced increase of insulin sensitivity in the muscles of the obese Zucker fa/fa rat cannot be explained by local adipocyte differentiation.
    Hallakou S; Foufelle F; Doaré L; Kergoat M; Ferré P
    Diabetologia; 1998 Aug; 41(8):963-8. PubMed ID: 9726600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPAR-gamma overexpression suppresses glucose-induced proinsulin biosynthesis and insulin release synergistically with pioglitazone in MIN6 cells.
    Nakamichi Y; Kikuta T; Ito E; Ohara-Imaizumi M; Nishiwaki C; Ishida H; Nagamatsu S
    Biochem Biophys Res Commun; 2003 Jul; 306(4):832-6. PubMed ID: 12821117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High glucose condition activates protein tyrosine phosphatases and deactivates insulin receptor function in insulin-sensitive rat 1 fibroblasts.
    Ide R; Maegawa H; Kikkawa R; Shigeta Y; Kashiwagi A
    Biochem Biophys Res Commun; 1994 May; 201(1):71-7. PubMed ID: 8198614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone attenuates the inhibitory effect of phorbol ester on epidermal growth factor receptor autophosphorylation and tyrosine kinase activity.
    Takata Y; Imamura T; Yang GH; Takada Y; Sawa T; Morioka H; Kobayashi M
    Biochim Biophys Acta; 1996 Jun; 1312(1):68-72. PubMed ID: 8679718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.
    Okada T; Wada J; Hida K; Eguchi J; Hashimoto I; Baba M; Yasuhara A; Shikata K; Makino H
    Diabetes; 2006 Jun; 55(6):1666-77. PubMed ID: 16731829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.